[1]
Sulaymanov D.A. and Yigitaliev A.B. 2026. THE SIGNIFICANCE OF KEY IMMUNE CYTOKINES AS DIAGNOSTIC AND PROGNOSTIC MARKERS IN THYROID CANCER DURING TREATMENT. TIBBIYOT ASOSLARI. 1, 16 (Oct. 2026), 18–23.